Press release archive

This is our response to the comments made at the Northern Ireland deal press conference by Ursula von der Leyen, in relation to Horizon Europe. 

Paul Schreier, incoming Interim CEO of Wellcome, congratulates Professor Matt Hurles on his appointment as Director of the Wellcome Sanger Institute.

Wellcome is calling on the perspectives of Black researchers in the UK to help shape funding that forms part of its diversity, equity and inclusion strategy. 

Beth Thompson, Interim Director of Strategy, responds to the establishment of new UK Government departments.

Wellcome announces £22.7 million for new cutting-edge digital tools to help transform preparations and responses to outbreaks of devastating diseases.

Dr Charlie Weller, Head of Infectious Disease Prevention at Wellcome, responds to the WHO decision not to declare an end to the Public Health Emergency of International Concern for Covid-19.

Wellcome directors share their priorities and predictions for 2023, across discovery research, mental health, climate and health, infectious diseases, and strategy.

Wellcome Director Dr Jeremy Farrar will take up the position of Chief Scientist of the World Health Organization after leaving Wellcome next year.

Martin Smith responds to the UK Government's Autumn Statement, including plans for research and development.

Charlie Weller, Head of Prevention at Wellcome, responds to the publication of the World Health Organization's Global tuberculosis report 2022.

Reaction to the announcement of Nusrat Ghani as the next UK Minister for Science and Investment Security.

Reaction to the announcement of Liz Truss as the next UK Prime Minister.

An evaluation of progress on anti-racism work at Wellcome has found insufficient action on ambitions the funder set out two years ago.

Statements issued by Wellcome in response to the global Monkeypox outbreak.

Dr Josie Golding responds to the WHO declaration of a Public Health Emergency of International Concern for Monkeypox.

Wellcome’s work is funded by the returns generated from our investment portfolio. 

The Science for Africa Foundation will receive more than £6.5mn in core funding over five years from Wellcome, which will help strengthen Africa's research ecosystem.

A major funding opportunity will support the development of evidence to advance practical solutions to mitigate the urgent climate crisis and lessen its effect on human health. 

Statement from Dr Gordon Dougan, Director of Infectious Diseases, on the decision not to declare a PHEIC in response to Monkeypox.